The Effect of the Thermosensitive Biodegradable PLGA⁻PEG⁻PLGA Copolymer on the Rheological, Structural and Mechanical Properties of Thixotropic Self-Hardening Tricalcium Phosphate Cement.


Journal

International journal of molecular sciences
ISSN: 1422-0067
Titre abrégé: Int J Mol Sci
Pays: Switzerland
ID NLM: 101092791

Informations de publication

Date de publication:
17 Jan 2019
Historique:
received: 03 11 2018
revised: 13 01 2019
accepted: 14 01 2019
entrez: 20 1 2019
pubmed: 20 1 2019
medline: 2 5 2019
Statut: epublish

Résumé

The current limitations of calcium phosphate cements (CPCs) used in the field of bone regeneration consist of their brittleness, low injectability, disintegration in body fluids and low biodegradability. Moreover, no method is currently available to measure the setting time of CPCs in correlation with the evolution of the setting reaction. The study proposes that it is possible to improve and tune the properties of CPCs via the addition of a thermosensitive, biodegradable, thixotropic copolymer based on poly(lactic acid), poly(glycolic acid) and poly(ethylene glycol) (PLGA⁻PEG⁻PLGA) which undergoes gelation under physiological conditions. The setting times of alpha-tricalcium phosphate (α-TCP) mixed with aqueous solutions of PLGA⁻PEG⁻PLGA determined by means of time-sweep curves revealed a lag phase during the dissolution of the α-TCP particles. The magnitude of the storage modulus at lag phase depends on the liquid to powder ratio, the copolymer concentration and temperature. A sharp increase in the storage modulus was observed at the time of the precipitation of calcium deficient hydroxyapatite (CDHA) crystals, representing the loss of paste workability. The PLGA⁻PEG⁻PLGA copolymer demonstrates the desired pseudoplastic rheological behaviour with a small decrease in shear stress and the rapid recovery of the viscous state once the shear is removed, thus preventing CPC phase separation and providing good cohesion. Preliminary cytocompatibility tests performed on human mesenchymal stem cells proved the suitability of the novel copolymer/α-TCP for the purposes of mini-invasive surgery.

Identifiants

pubmed: 30658476
pii: ijms20020391
doi: 10.3390/ijms20020391
pmc: PMC6359562
pii:
doi:

Substances chimiques

Biocompatible Materials 0
Bone Cements 0
Calcium Phosphates 0
Polyesters 0
poly(lactic-glycolic acid)-poly(ethyleneglycol) copolymer 0
polyethylene glycol-poly(lactide-co-glycolide) 0
Polyglactin 910 34346-01-5
Polyethylene Glycols 3WJQ0SDW1A
tricalcium phosphate K4C08XP666

Types de publication

Journal Article

Langues

eng

Sous-ensembles de citation

IM

Subventions

Organisme : Ministerstvo Školství, Mládeže a Tělovýchovy
ID : LQ1601
Organisme : Ministerstvo Zdravotnictví Ceské Republiky
ID : NV18-05-00379
Organisme : AOTRAUMA Switzerland
ID : AOTEU-R-2016-064
Organisme : Horizon 2020 Framework Programme
ID : 665860

Références

Biomaterials. 2004 Jun;25(14):2893-9
pubmed: 14962568
J Mater Sci Mater Med. 2000 Jun;11(6):365-71
pubmed: 15348018
J Mater Sci Mater Med. 2001 Oct-Dec;12(10-12):905-9
pubmed: 15348338
Biomaterials. 2005 May;26(13):1553-63
pubmed: 15522757
Int J Pharm. 2005 Apr 27;294(1-2):103-12
pubmed: 15814234
Biomaterials. 2005 Nov;26(33):6423-9
pubmed: 15964620
Biomed Mater Eng. 2005;15(4):279-88
pubmed: 16010036
J Biomed Mater Res B Appl Biomater. 2006 Aug;78(2):259-64
pubmed: 16362962
Biomaterials. 2006 Oct;27(29):5003-13
pubmed: 16787661
J Control Release. 2007 Oct 8;122(3):338-44
pubmed: 17644208
J Mater Sci Mater Med. 2009 Apr;20(4):935-41
pubmed: 19052849
Acta Biomater. 2009 Sep;5(7):2752-62
pubmed: 19357005
J Mater Sci Mater Med. 2010 Nov;21(11):3039-48
pubmed: 20857322
J Biomed Mater Res A. 2012 Mar;100(3):712-9
pubmed: 22213632
Adv Drug Deliv Rev. 2012 Sep;64(12):1090-110
pubmed: 22310160
Acta Biomater. 2012 Nov;8(11):4043-52
pubmed: 22800604
J Mater Sci Mater Med. 2013 Feb;24(2):381-93
pubmed: 23104087
Acta Biomater. 2013 Apr;9(4):6188-98
pubmed: 23219844
Anal Chim Acta. 2014 Jan 15;808:18-43
pubmed: 24370091
Acta Biomater. 2015 Jan;12:242-249
pubmed: 25448348
Carbohydr Polym. 2015 Aug 1;126:130-40
pubmed: 25933531
J Mater Sci Mater Med. 2016 Mar;27(3):58
pubmed: 26787490
Mater Sci Eng C Mater Biol Appl. 2016 Dec 1;69:1201-9
pubmed: 27612818
Acta Biomater. 2017 Mar 1;50:1-19
pubmed: 27838464
Acta Biomater. 2017 Feb;49:563-574
pubmed: 27872015
Tissue Eng Part A. 2017 Dec;23(23-24):1297-1309
pubmed: 28107811
Acta Biomater. 2017 Sep 15;60:81-92
pubmed: 28739544
Acta Biomater. 2018 Sep 15;78:341-350
pubmed: 30075321
Exp Cell Res. 1988 Apr;175(2):266-76
pubmed: 3360056
J Bone Joint Surg Am. 1977 Oct;59(7):954-62
pubmed: 561786
J Dent Res. 1997 Apr;76(4):905-12
pubmed: 9126187
J Bone Joint Surg Am. 1998 Aug;80(8):1112-24
pubmed: 9730120
Proc Inst Mech Eng H. 1998;212(6):427-35
pubmed: 9852738

Auteurs

Lucy Vojtova (L)

CEITEC ⁻ Brno University of Technology, Purkynova 656/123, 612 00 Brno, Czech Republic. lucy.vojtova@ceitec.vutbr.cz.

Lenka Michlovska (L)

CEITEC ⁻ Brno University of Technology, Purkynova 656/123, 612 00 Brno, Czech Republic. lenka.michlovska@ceitec.vutbr.cz.

Kristyna Valova (K)

CEITEC ⁻ Brno University of Technology, Purkynova 656/123, 612 00 Brno, Czech Republic. kristyna.valova@ceitec.vutbr.cz.

Marek Zboncak (M)

CEITEC ⁻ Brno University of Technology, Purkynova 656/123, 612 00 Brno, Czech Republic. marek.zboncak@ceitec.vutbr.cz.

Martin Trunec (M)

CEITEC ⁻ Brno University of Technology, Purkynova 656/123, 612 00 Brno, Czech Republic. martin.trunec@ceitec.vutbr.cz.

Klara Castkova (K)

CEITEC ⁻ Brno University of Technology, Purkynova 656/123, 612 00 Brno, Czech Republic. klara.castkova@ceitec.vutbr.cz.

Milan Krticka (M)

Trauma Surgery Department, The University Hospital Brno, Jihlavska 340/20, 325 00 Brno, Czech Republic. mil.krticka@gmail.com.

Veronika Pavlinakova (V)

CEITEC ⁻ Brno University of Technology, Purkynova 656/123, 612 00 Brno, Czech Republic. veronika.svachova@ceitec.vutbr.cz.

Petr Polacek (P)

CEITEC ⁻ Brno University of Technology, Purkynova 656/123, 612 00 Brno, Czech Republic. petr.polacek@ceitec.vutbr.cz.

Matej Dzurov (M)

CEITEC ⁻ Brno University of Technology, Purkynova 656/123, 612 00 Brno, Czech Republic. xcdrzurov@fch.vut.cz.

Vera Lukasova (V)

Lab of Tissue Engineering, Institute of Experimental Medicine, Czech Academy of Sciences, Videnska 1083, 14240 Prague, Czech Republic. vera.lukasova@iem.cas.cz.

Michala Rampichova (M)

Lab of Tissue Engineering, Institute of Experimental Medicine, Czech Academy of Sciences, Videnska 1083, 14240 Prague, Czech Republic. michala.rampichova@iem.cas.cz.

Tomas Suchy (T)

Department of Composites and Carbon Materials, Institute of Rock Structure and Mechanics, The Czech Academy of Sciences, V Holesovickach 41, 182 09 Prague, Czech Republic. suchy@irsm.cas.cz.
Department of Mechanics, Biomechanics and Mechatronics, Faculty of Mechanical Engineering, Czech Technical University in Prague, Technicka 4, 166 07 Prague, Czech Republic. suchy@irsm.cas.cz.

Radek Sedlacek (R)

Department of Mechanics, Biomechanics and Mechatronics, Faculty of Mechanical Engineering, Czech Technical University in Prague, Technicka 4, 166 07 Prague, Czech Republic. radek.sedlacek@fs.cvut.cz.

Maria-Pau Ginebra (MP)

Biomaterials, Biomechanics and Tissue Engineering Group, Department of Materials Science and Metallurgical Engineering, Universitat Politècnica de Catalunya, 08019 Barcelona, Spain. maria.pau.ginebra@upc.edu.

Edgar B Montufar (EB)

CEITEC ⁻ Brno University of Technology, Purkynova 656/123, 612 00 Brno, Czech Republic. eb.montufar@ceitec.vutbr.cz.

Articles similaires

[Redispensing of expensive oral anticancer medicines: a practical application].

Lisanne N van Merendonk, Kübra Akgöl, Bastiaan Nuijen
1.00
Humans Antineoplastic Agents Administration, Oral Drug Costs Counterfeit Drugs

Smoking Cessation and Incident Cardiovascular Disease.

Jun Hwan Cho, Seung Yong Shin, Hoseob Kim et al.
1.00
Humans Male Smoking Cessation Cardiovascular Diseases Female
Humans United States Aged Cross-Sectional Studies Medicare Part C
1.00
Humans Yoga Low Back Pain Female Male

Classifications MeSH